Dashboard
Poor Management Efficiency with a low ROCE of 2.34%
- The company has been able to generate a Return on Capital Employed (avg) of 2.34% signifying low profitability per unit of total capital (equity and debt)
Low ability to service debt as the company has a high Debt to EBITDA ratio of 11.16 times
Healthy long term growth as Operating profit has grown by an annual rate 66.73%
The company has declared Positive results for the last 5 consecutive quarters
Stock is technically in a Mildly Bullish range
Stock DNA
Pharmaceuticals & Biotechnology
INR 35,289 Cr (Small Cap)
89.00
40
0.00%
0.30
7.76%
6.89
Total Returns (Price + Dividend) 
Latest dividend: 9.215186403508772 per share ex-dividend date: Nov-17-2016
Risk Adjusted Returns v/s 
Returns Beta
News

Wockhardt Ltd Surges 8.16% to Day's High of Rs 2195 — Outperforms Sector by 7.62 Percentage Points
The Sensex advanced 1.01% on 19 Nov 2026, yet Wockhardt Ltd outpaced the broader market with an 8.16% gain, reaching an intraday high of Rs 2195. This 7.62 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a market-wide surge.
Read More
Wockhardt Ltd is Rated Hold by MarketsMOJO
Wockhardt Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Wockhardt Ltd is Rated Hold by MarketsMOJO
Wockhardt Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 November 2026, providing investors with the most recent insights into the stock’s performance and outlook.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Change in Management
09-Nov-2026 | Source : BSEPursuant to Regulation 30 of SEBI LODR Regulations 2015 read with Schedule III thereto we wish to inform you that Mr. Vinesh Kumar Jairath (DIN: 00391684) has completed his second consecutive term of five years as Non-Executive Independent Director of the Company and accordingly ceased to be a Director of the Company upon conclusion of business hours of November 9 2026.
Quarter And Half Year Ended September 30 2026.
02-Nov-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of directors at its meeting held today i.e. 2nd November 2026 inter-alia has approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September 2026.
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
02-Nov-2026 | Source : BSEPlease refer the attachment.
Corporate Actions 
No Upcoming Board Meetings
Wockhardt Ltd has declared 200% dividend, ex-date: 17 Nov 16
No Splits history available
No Bonus history available
Wockhardt Ltd has announced 3:10 rights issue, ex-date: 08 Mar 22
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
9.9723
Held by 25 Schemes (5.99%)
Held by 120 FIIs (7.02%)
Themisto Trustee Company Private Limited (40.39%)
Tata Mutual Fund - Tata Small Cap Fund (2.03%)
26.9%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 4.31% vs -3.73% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -25.47% vs -36.14% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -1.81% vs 10.81% in Sep 2024
Growth in half year ended Sep 2025 is 66.67% vs 82.94% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 6.13% vs 8.15% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 313.64% vs 92.52% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 11.99% vs 7.65% in Mar 2025
YoY Growth in year ended Mar 2026 is 553.19% vs 89.85% in Mar 2025